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SUMMARY 
In all tissues that have been studied to date, dendritic leucocytes constitute only a small proportion 
of total cells and are difficult both to isolate .and purify. This study reports on a method for the 
propagation of large numbers of dendritic cells (DC) from mouse spleen using granulocyte-
macrophage colony-stimulating factor (GM-CSF) and their characteristics. Within a few days of 
liquid culture in GM-CSF, BIO BR (H-2\ I-E+) mouse splenocytes formed loosely adherent 
myeloid cell clusters. Mononuclear progeny released from these clusters at and beyond 4 days 
exhibited distinct dendritic morphology and strongly expressed leucocyte common antigen 
(CD45), CD II b, heat-stable antigen, Pgp-I (CD44) and intercellular adhesion molecule-I (ICAM-
1: CD54). The intensity of expression of the DC-restricted markers NLDC 145 and 33DI, the 
macrophage marker F4/80, and FcyRII (CDw32) was low to moderate, whereas the cells were 
negative for CD3, CD45RA and NKl.l. High and moderate levels, respectively, of cell surface 
staining for major histocompatibility complex (MHC) class II (I_Ek) and the B7 antigens (counter-
receptors of CTLA4, a structural homologue of CD28) were associated with potent stimulation of 
unprimed, allogeneic T cells (BIO; H_2b, I-E-). DC propagated in a similar fashion from DBA/2 
mouse spleen proved to be strong antigen-presenting cells (APC) for MHC-restricted, syngeneic T-
helper type 2 (Th2) cell clones specifically responsive to sperm whale myoglobin. Footpad or 
intravenous injection of GM-CSF-stimulated BIO.BR spleen-derived DC into BIO (H_2b, I-E-) 
recipients resulted in homing of the allogeneic cells to T -cell-dependent areas of lymph nodes and 
spleen, where they strongly expressed donor MHC class II antigen 1-2 days later. These findings 
indicate that cells can be propagated from fresh splenocyte suspensions that exhibit distinctive 
features of DC. namely morphology, motility, cell-surface phenotype, potent allogeneic and 
syngeneic APC function and in vivo homing ability. Propagation of DC in this manner from 
progenitors present in lymphoid tissue provides an alternative and relatively convenient source of 
high numbers of these otherwise difficult to isolate but functionally important APC. 
INTRODUCTION 
Dendritic cells (DC) were first isolated from mouse lymphoid 
tissues during studies on the function of accessory cells in 
immune responses. l They constitute a minor population of 
bone marrow-derived leucocytes that is distributed ubiqui-
tously throughout the body. In contrast to macrophages, from 
which they differ on a number of morphological, phenotypic, 
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enzymatic and behavioural criteria,2-4 mature DC constitu-
tively express high levels of cell-surface major histocompat-
ibility complex (MHC) class II molecules and are the most 
potent initiators ofT -lymphocyte responses, both in vitro and in 
vivo.2- 4 DC within secondary lymphoid tissues are present as 
interdigitating cells in T-cell areas (white pulp of spleen and 
paracortex of lymph nodes) and in the marginal zone of the 
spleen.s These cells represent the major MHC class II-positive 
stimulatory cell type within the spleen. The identity of critical 
costimulatory signals for resting T cells expressed by mature 
DC has, however, remained elusive. Recent evidence, based on 
studies of murine epidermal Langerhans' cells, suggests that up-
regulation of cell-surface expression of CD80 (formerly termed 
B7 or BBI), the counter-receptor for the T-cell activation 
molecule CD28, may correlate with the functional maturation 
of DC.6 
Studies on the properties and functional maturation of DC 
128 L. Lu et al. 
have been restricted by the rarity of cells that meet criteria for 
classification as DC « 1 % of unfractionated spleen cells) and 
by the failure of such cells to survive beyond a few days or to 
grow in culture. Recently, however, DC progenitors have been 
propagated in response to granulocyte-macrophage colony-
stimulating factor (GM-CSF) from precursors present in 
mouse bone marrow? and blood.s In addition, we have 
shown that DC lineage cells can be induced to proliferate in 
response to this cytokine from progenitors present in mouse 
liver.9 In this study, we report on the propagation of DC from 
GM-CSF-stimulated progenitors present in unfractionated 
spleen cell suspensions. We have characterized these DC in 
terms of their phenotype and function, with particular regard to 
their role as inducers of T-cell activation. 
MATERIALS AND METHODS 
Animals 
Adult 8-l2-week-old male BlO.BR (H_2k, I-E+), C57BLI 
lOSnJ (BlO, H_2b, I-E-) and DBA/2 (H_2d) mice were 
purchased from the Jackson Laboratory (Bar Harbor, ME). 
They were maintained in the specific pathogen-free facility of 
the University of Pittsburgh Medical Center. 
Isolation and propagation of spleen cells 
Fresh splenocytes were obtained by teasing the spleens under 
aseptic conditions; single-cell suspensions were prepared using 
standard procedures. Erythrocytes were removed by osmotic 
lysis. The nucleated cells were washed twice (5 min at 400g) in 
RPMI-1640 (Gibco BRL, Grand Island, NY) supplemented 
with glutamine (2 DlM/ml), non-essential amino acids (0'1 mMI 
ml), sodium pyruvate (1 mM/ml), 2-mercaptoethanol (20,LlM), 
antibiotics (penicillin, 100 U Iml; streptomycin, 100 mg/ml) 
(complete medium) and 5% heat-activated fetal bovine serum 
(HIFBS; Gibco). To test the capacity of the spleen cells to 
proliferate in response to GM-CSF, 1-2 x 106 cells were 
placed in each well of a 24-well plate in 1 ml of complete 
medium, supplemented with 10% HIFBS and 0'4ng/ml mouse 
recombinant (r) GM-CSF (R&D Systems, Minneapolis, MN). 
The cultures were 'fed' with GM -CSF every 48 hr by aspirating 
50% of the supernatant, after gentle swirling, and replenishing 
with an equivalent volume of fresh, GM-CSF-supplemented 
medium. An objective of these washes was to remove non-
adherent granulocytes without dislodging clusters of develop-
ing DC that had attached loosely to firmly adherent 
macrophages.? After 4 days, granulocytes were no longer 
significant contaminants of the cultures. These were maintained 
routinely for up to 10 days, at which time non-adherent cells 
released from growing clusters were harvested. In this manner, 
approximately 1·5 x 106 DC/spleen were obtained by day 10. 
Flow cytometric analysis 
GM-CSF-stimulated spleen cells were washed in complete 
medium (2 x 5 min each), then resuspended (5 x lOS/tube) in 
Hanks' balanced salt solution (HBSS) with 1 % w/v bovine 
serum albumin (BSA; Sigma, St Louis, MO) and 0'1 % sodium 
azide (Sigma). They were stained either by direct or indirect 
immunofluorescence using a panel of monoclonal antibodies 
(mAb). T lymphocytes were identified using phycoerythrin 
(pE)-conjugated hamster anti-mouse CD3-e (pharMingen, San 
Diego, CA). For the detection of B cells, rat anti-mouse B220 
(CD45RA; TIB146; ATCC, Rockville, MD) was used, 
followed by FITC-conjugated AffiniPure goat anti-rat IgG 
(Jackson Immunoresearch Labs Inc., West Grove, PA). Anti-
leucocyte common antigen (CD45; TIB122; ATCC), anti-
macrophage antibody (F4/80; HB198; ATCC), anti-heat-stable 
antigen (JllD; TIB183; ATCC) and antibodies directed against 
DC-restricted markers (NLDC-145, derived from Kraal et 
al.,10 and 33DI; TIB227; ATCC; kindly provided by Dr R. M. 
Steinman, Rockefeller University, New York, NY) were 
employed to characterize further the lineages of the isolated 
cells. The presence of natural killer (NK) cells was revealed 
using antibody against NKl.1 (Dr W. H. Chambers, Depart-
ment of Pathology, University of Pittsburgh). The expression 
of accessory molecules was identified using antibodies against 
the interleukin-2 (IL-2) receptor (CD25; p55, PC6l 5.3; 
TIB222; ATCC), intercellular adhesion molecule-l (ICAM-l; 
CD54; Serotec, Indianapolis, IN), Pgp-l glycoprotein (CD44; 
TIB235; ATCC), CDIlb (MAC-loe unit, Ml/70; TIB128; 
ATCC) and FcyRII (CDw32; PharMingen). Appropriate 
FITC-conjugated anti-mouse, anti-rat or anti-hamster second-
ary antibodies were used. Normal hamster serum or the 
appropriate rat immunoglobulin isotypes were used as nega-
tive controls. Biotin-conjugated mouse anti-mouse I_Ek,d,p,r 
(PharMingen) was used with FITC-steptavidin (Jackson 
Immunoresearch Labs) as the secondary reagent. Biotin-
conjugated mouse IgG2a, together with FITC-streptavidin, 
was used as a negative control. 
To identify counter-receptors of CTLA4 (a structural 
homologue of CD28), which include CD80 (B7-l) and CD86 
(B7-2), the cells were first incubated with either human 
immunoglobulin (Sigma) as a negative control or with the 
CTLA4-immunoglobulin fusion protein (2'5 Itg/ml; kindly 
provided by Dr P. S. Linsley, Bristol Myers Squibb 
Pharmaceutical Research Institute, Seattle, W A), which 
contains the extracellular portion of human CTLA4 and a 
human IgGyl chain. ll They were washed and incubated 
with FITC-conjugated mouse IgG2a anti-human IgG (Fc; 
Sigma). Lipopolysaccharide (LPS)-activated splenic B-cell 
blasts, which express B7/BBl,6 served as positive controls. 
After staining, the cells were fixed in 1 % v/v paraformaldehyde 
before analysis in a FACSTAR@ flow cytometer (Becton 
Dickinson, San Jose, CA). Five thousand events were acquired 
for each sample. 
Immunocytochemistry 
Cytocentrifuge preparations were stained either directly or 
indirectly using avidin-biotin-peroxidase complex (ABC)-
staining procedures. Briefly, specimens were air-dried at room 
temperature, before fixing in acetone for 5 min. The slides were 
then washed in phosphate-buffered saline (PBS) and incubated 
for 1 hr at room temperature with biotinylated mouse IgG2a, 
anti-mouse I_Ek,d,p,r mAb. For indirect staining, primary rat 
anti-CD45, anti-NLDC145 or anti-2Al (a gift from Dr R. M. 
Steinman) mAb were used (1 hr at room temperature) followed 
by biotinylated mouse IgG F(ab')z anti-rat IgG (Accurate 
Chemical and Scientific Corporation, Westbury, NY), for 1 hr 
at room temperature. After three washes of 5 min each in PBS, 
the slides were incubated with streptavidin-biotin-peroxidase 
complex (ABC-P; Boehringer Mannheim Corp., Indianapolis, 
IN) for 30 min at room temperature, and the colour reaction 
was developed for 6 min using a peroxidase chromogen kit 
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Figure 1. Phase-contrast micrographs illustrating the development and isolation of normal mouse spleen-derived DC in liquid cultures 
supplemented with GM-CSF. (a) An early aggregate of proliferating, putative DC progenitors (day 4) attached to strongly adherent 
macrophages and showing typical, loosely adherent cells (arrows) that were released from the aggregates. At 2 and 4 days, non-
adherent granulocytes were removed by gentle aspiration of the supernatant and replaced with fresh, GM-CSF-supplemented 
medium. Magnification, x 100. (b) Higher power view of typical, non-adherent cells with cytoplasmic processes released from 
aggregates and harvested after 10 days of culture. Magnification, x 400. 
Figure 2. Giemsa-stained cytocentrifuge preparation showing cells 
released from GM-CSF-stimulatcd splccn ccl! aggrcgates (day 10), 
which exhibit irregular-shaped eccentric nuclei, variable degrees of 
cytoplasmic vacuolation, absence of prominent granules and distinct 
cytoplasmic processes. Magnification, x 600. Inset, immunoperoxidase-
stained preparation, showing a high level of MHC class II (I_Ek) 
antigen expression on dendritic-shaped cells (also day 10). Magnifica-
tion, x 600. 
(AEC; Biomedia Corp., Foster City, CA). Cells were counter-
stained lightly with haematoxylin. Controls included the 
omission of antibody and the use of isotype-matched 
irrelevant mAb. 
Mixed leucocyte cultures 
To test the immunogenicity of freshly isolated or cultured 
spleen cells, one-way mixed leucocyte cultures (4 x 105 cells in 
200 fll/well) in 96-well, round-bottomed microculture plates 
(Falcon®; Becton Dickinson Labware, Lincoln Park, NJ) were 
performed with variable numbers of y-irradiated (20 Gy) 
allogeneic (BIO.BR) or syngeneic (BIO) spleen-derived cells as 
stimulators. BIO spleen cells were used as responders, which 
were T-cell enriched by passage (1 hr at 37°) through a nylon 
wool column. In some experiments, designed to examine the 
functional expression ofB7 antigens, CTLA4-immunoglobulin 
fusion protein (2'5 flg/ml) or human immunoglobulin was 
added at the start of the cultures. The cells were maintained 
in complete medium supplemented with 10% HIFBS for 
(a) (b) (e) 
Figure 3. Immunoperoxidase labelling of cultured cells harvested after 
10 days to show additional phenotypic features of released DC progeny. 
The primary mAb were (a) an li-CD45 (leucocyte common antigen; 
ATCC; TIBI22), (b) NLDC-145 anti-interdigitating cell, 10 ancl (c) 2AI, 
which reacts primarily with granules within the cytoplasm of cultured 
DC in vitro 8 Magnification, x 600. 
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72hr in 5% CO2 in air; for the finalI8hr, lOpl eHjthymidine 
(eHjTdR; 1 pCi) was added to each well. Cultures were 
harvested onto glass fibre disks using a multiple cell 
harvester, and the degree of thymidine incorporation was 
determined in a liquid scintillation counter. Results were 
expressed as means (c.p.m.) ± 1 SD. 
Stimulation of syngeneic Th2 cell clone 
The sperm whale myoglobin (SpWMb)-specific T-cell clone, 
13.26, was used in proliferation assays with varying numbers of 
spleen-derived DBA/2 cells in the presence and absence of 
specific antigen. The T-cell clone 13.26 has been described 
previouslyl2 and is specific for a SpWMb peptide spanning 
amino acids 132-147. To test the ability offreshly isolated or 
cultured spleen cells to stimulate proliferation of the clone, 
5 x I04T cells/well were cultured with varying numbers of 
spleen-derived cells in the presence or absence of Sp WMb 
peptide 132-147 (20 pg/ml) in 200 pi of medium in 96-well flat-
bottomed microtitre plates. The cells were incubated for 48 hr 
at 37°, pulsed with 0'5pCi eHjTdR for an additional 24hr, 
harvested and counted in a p-scintillation counter. 
DC homing 
GM-CSF-stimulated BlO.BR spleen cells were washed in 
RPMI-I640 and injected subcutaneously (s.c.) (lor 2·5 x 105 
cells in 50 pi) into one hind footpad, or intravenously (i.v.) 
(1 x 106 in 200 pi) via the lateral tail vein, of normal allogeneic 
BlO mice. One and 2 days later, the draining popliteal lymph 
nodes (where appropriate) and spleen were removed and 
embedded in Tissue-Tek® (OCT Compound; Miles Inc., 
Elkhart, IN) before freezing at - 70°. Sections (10 Jlffi) were 
cut using a cryostat microtome at - 30° and melted directly 
onto slides at room temperature, then air-dried. After brief 
acetone fixation, immunoperoxidase staining was performed, 
as described above. Controls included sections of normal 
recipient strain (BlO) tissues. 
RESULTS 
Proliferation of spleen cells in response to GM-SCF 
Since it has been reported recently that large numbers of DC 
can be induced to proliferate from mouse blood or bone 
marrow when cultured with GM_CSF,7,8 we determined 
whether, using a similar approach, spleen-derived DC could 
be generated in liquid culture. After 4 days culture of freshly 
isolated splenocytes, during which time non-adherent granulo-
cytes and mature DC were removed by gentle washes, growth 
of cell 'clusters' attached to a layer of adherent cells was evident 
(Fig. Ia); many low buoyant density, dendritic-shaped cells 
appeared to have been released from the clusters and exhibited 
cytoplasmic processes (Fig. Ib). With more prolonged culture 
in GM-CSF, these dendritic-shaped, loosely attached cells 
continued to detach from the clusters and float in the culture 
medium. In the absence ofGM-CSF, no clusters were observed 
and cells did not proliferate. Macrophages and fibroblasts also 
expanded in the GM-CSF-stimulated cultures, but remained 
attached firmly to the plastic surface. Floating or loosely 
adherent, putative DC were harvested by gentle aspiration for 
various analyses. Approximately 1·5 x 106 of these cells could 
be recovered consistently at 10 days from cultures derived from 
a single spleen (0'7-1 x 108 nucleated cells). This represented 
an increase of lO-fold over the number of mature DC/spleen 
that could be isolated in our laboratory using conventional 
procedures. I,l3 
Microscopic and immunophenotypic analysis of GM-CSF-
stimulated spleen cells 
At the microscopic level, most of the cells released from 
proliferating aggregates of GM-CSF-stimulated cells exhibited 
typical morphological features of DC, including (in many but 
not all cells) irregular shape, eccentric nuclei, numerous 
cytoplasmic dendrites, and absence of prominent cytoplasmic 
granules (Fig. 2). The cells with dendritic morphology were 
strongly MHC class 11+ (I_Ek +) (Fig. 2 inset), as described 
previously for cultured blood-derived DC,8 and expressed 
CD45 (leucocyte common antigen), the DC-restricted marker 
NLDC-145 (interdigitating cells) and the DC-restricted granule 
antigen 2Al (Fig. 3). In order to characterize further the surface 
phenotype of cells released from proliferating aggregates, flow 
cytometric analysis was performed after 7-10 days culture in 
GM-CSF. Staining for cells oflymphoid lineage, including NK 
cells, was absent. As shown in Fig. 4, the floating cells strongly 
expressed surface antigens that are known to be associated with 
mouse DC. These included CD45, heat-stable antigen (J1ID), 
ICAM-I (CD54), CDIlb (MAC-I) and CD44 (non-polymeric 
determinant of Pgp-I glycoprotein). In addition, staining of 
weak to moderate intensity was observed for the DC-restricted 
markers NLDC-145 and 33Dl and for F4/80 and FCl'RII. 
F ACS analysis also confirmed that the cells expressed a high 
intensity of Cell-surface MHC class II (I_Ek). Moreover, they 
stained for counter-receptors of CTLA4, a structural homo-
logue of CD28 (Fig. 5). 
Allostimulatory activity of GM-CSF -propagated spleen DC 
and the role of B7 antigens 
The spleen-derived DC that expressed high levels of cell-surface 
MHC class II antigen and moderate levels of B7 antigens were 
potent inducers of 3-day, primary allogeneic T-cell responses 
(Fig. 6). They were much more effective than freshly isolated 
spleen cells, although less stimulatory than LPS-activated B-
cell blasts at the cell concentrations used (Fig. 7). To examine 
the functional expression of B7 antigens and other CTLA4 
counter-receptors, CTLA4-immunoglobulin fusion protein 
was added at the start of the cultures. Complete inhibition of 
the mixed lymphocyte reaction (MLR) induced by the spleen-
derived DC was observed (Fig. 7), indicating the crucial role of 
CTLA4 counter-receptors, including costimulatory B7 anti-
gens, in the activation of unprimed T cells by the cultured DC. 
Activation of syngeneic T-cell clones 
The spleen-derived DC were also potent stimulators of antigen-
specific T-cell activation. Significant proliferation of the 
SpWMb-specific Th2 clone 13.26 was observed with as few as 
300 spleen-derived DC, with peak proliferation observed with 
3000 stimulator cells/well (Fig. 8). In contrast, freshly isolated 
spleen cells were much less efficient. 
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Figure 4. Merged FACSCAN@ immunophenotypic profiles of the GM-CSF-stimulated spleen-derived DC released from cell 
aggregates in liquid culture (day 10) and examined using rat, hamster or mouse mAb as detailed in the Materials and Meth9ds. All data 
were obtained from the same cell preparation at the same time. The result is representative of three separate experiments performed 
using cells obtained from 6-1O-day cultures. 
In vivo homing of spleen-derived DC 
A specialized property of DC is their capacity to 'home' to T-
dependent areas of peripheral lymphoid tissues. 14,15 To 
determine the homing ability of the spleen DC propagated in 
culture, lO-day GM-CSF-stimulated cells were injected s.c. into 
one hind footpad or i.v. into allogeneic BlO (I-E-) recipients. 
One and 2 days later, the mice were killed and cryostat sections 
of the draining lymph nodes (where appropriate) and spleens 
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Figure 5. Flow cytometric analysis of MHC class II (I_Ek) and CTLA4-
immunoglobulin counter-receptor expression on GM-CSF-stimulatcd 
mouse spleen-derived DC released from proliferating aggregates in 10-
day cultures. The result is representative of three separate experiments. 
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were stained with donor-specific mAb to I-Ek As shown in Fig. 
9, spleen-derived cells propagated in GM-CSF-supplemented 
cultures homed almost exclusively to T-cell areas of the 
recipients' spleens in close proximity to arterioles. Similar 
observations were made in the draining lymph nodes of 
footpad-injected mice (data not shown). Moderate to intense 
I_Ek expression was detected on the spleen-derived cells, many 
of which also exhibited distinct dendritic morphology. As 
previously reported for non-lymphoid organ DC,14- 17 the 
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derived cells D C (I-E +) released in culture from proliferating cell 
aggregates (harvested on day 10). The cells (2·5 x 105) were injected s.c 
(day 0) into one hind footpad of BIO (I-E-) recipients and detec ted by 
immunohistochemistry in cryostat sections of spleen I or 2 days later. 
The spleen sections were stained using the ABC peroxidase procedure 
with donor-specific mouse anti-I-Ek mAb with appropriate controls. (a) 
Strongly MHC class II-positive cetls (one of which is arrowed) 
were detected in the periarteriolar lymphatic sheath. Magnification, 
x 45. (b) At higher magnification, cells with dendritic morphology were 
readily identified in the T-dependent areas in close proximity to 
arterioles; day 2. Magnification, x 400. 
spleen DC propagated in culture also exhibited a key functional 
property of this cell lineage-the capacity to home to T-
dependent areas of secondary lymphoid tissue and therein to 
express strong MHC class II cell-surface antigen. 
DISCUSSION 
Previous estimates of the frequency of the prototypic DC in 
mouse spleen have been about 0·1-0·3% of nucleated cells, 
with yields of approximately 2-5 x 105jspleen I 8,19 Similar 
results are obtained whether the DC are sorted t8 or isolated by 
more traditional adherencej rosetting methods, 19 which deplete 
contaminating macrophages. Once isolated, spleen Dare 
exquisitely dependent on GM-CSF for survival beyond I day of 
culture. To our knowledge, growth of splenic DC has not been 
reported in response to GM-CSF, nor has viability been 
maintained in culture for more than a few days.18 Until 
recently, it has proved difficult to generate DC in cultures of 
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bone marrow,20,21 from which these cells are ultimately derived, 
and little is known about the properties of progenitors cells of 
DC in spleen and other tissues. 
Within the last 2 years, however, GM-CSF-dependent 
proliferating DC progenitors that give rise to large numbers of 
typical, mature DC have been identified in mouse blood,8 bone 
marrow7 and liver.9 Initially, these studies centred on those 
murine tissues believed to be relatively deficient in mature DC 
(e.g. blood and bone marrow). More recently, propagation of 
DC progenitors for normal mouse liver9 has shown that tissues 
from which Ia + mature DC can be isolated using conventional 
procedures22 also contain Ia - progenitors of these cells. In the 
present study, the use of culture techniques which we have 
shown to facilitate the growth of DC progenitors from 
unfractionated, non-parenchymal cells in normal mouse 
liver,9 also promoted the growth and differentiation of DC 
progenitors present in fresh spleen cell suspensions. The 
identity of the cells was confirmed by their morphology, 
immunophenotypic characteristics, antigen-presenting func-
tion and in vivo homing ability, all of which conformed to 
that of 'classical' murine splenic DC.1-4 
Flow cytometric analysis of the GM-CSF-stimulated 
spleen-derived DC revealed many surface molecules character-
istically associated with mouse DC; including leucocyte 
common antigen (CD45), heat-stable antigen (JlID), ICAM-
I (CD54), CDllb (MAC-I) and CD44 (non-polymorphic 
determinant of Pgp-I glycoprotein). In addition, staining of 
moderate intensity was observed for the DC lineage-restricted 
markers NLDC-145 (interdigitating cells) and 33DI, for the 
DC-restricted granule antigen 2AI and for F4/S0 and FcyRiI. 
Similar observations for each of these markers have recently 
been made on DC released from proliferating aggregates in 
cultures of GM-CSF-stimulated mouse blood or bone 
marrow.7,8 In keeping with these latter findings on circulating 
or bone marrow DC progenitors, the spleen-derived, GM-CSF-
stimulated cells expressed very high levels of the MHC class II 
surface antigen molecule. The cultured splenic DC also 
expressed moderate intensity of counter-receptors/ligands (B7 
antigens) for CTLA4 (the structural homologue of CD2S). 
Moreover, in blocking experiments, we found that CTLA4 
counter-receptors on the cultured DC were required for 
proliferation of unprimed, allogeneic splenic T cells in primary 
mixed leucocyte reactions. These findings confirm recent 
observations of moderate cell-surface immunofluorescence 
staining and functional expression of B7/BBI (CDSO) on low 
density, transiently adherent DC-enriched populations isolated 
from mouse spleen cells suspensions6 using conventional 
procedures. 23 
The intense cell-surface expression of MHC class II (I_Ek) 
and accompanying staining for B7 antigens was associated with 
potent antigen-presenting activity of the GM-CSF-stimulated 
spleen DC, both for allogeneic (I-E-) naive T cells and for 
antigen-driven proliferation of syngeneic (I_Ad) Th cell clones 
specifically responsive to sperm whale myoglobin. Recent find-
ings suggest that up-regulation of the expression of B7 antigens 
on maturing mouse Langerhans' cells is of critical importance 
in the development of their capacity to activate naive T cells.6 
A specialized property of DC is their ability to home to T-
cell areas of peripheral lymphoid tissues.8,14,15.17,24 Donor-
derived DC expressing high levels of alloantigens have 
previously been identified within the spleens of unmodified 
murine allograft recipients, 1-4 days after heart transplanta-
tion14 and up to 1 year after liver transplantation. 16 To test the 
homing capacity of the splenic DC (I-E+) produced in culture, 
cells were either injected into the footpad or i.v. into 
unmodified, allogeneic (I-E-) recipients. The precise homing 
of these MHC class 11+ DC progeny to T-cell areas of the 
spleen confirmed the lineage of the cells and, together with our 
in vitro observations, indicated the potential of the GM-CSF-
cultured cells to act as potent APC in vivo. In vitro, however, 
cytokines other than GM-CSF, such as tumour necrosis 
factor-IX (TNF-IX) and IL_425 may also affect their maturation 
and functional status. 
Whilst mature or 'steady state' murine spleen DC (e.g. 
N4IS+ 'sorted' cells) fail to propagate in vitro in response to 
cytokines, it appears that GM-CSF-responsive progenitors 
present in bone marrow,7,26 blood,8liver9 and (as shown in this 
study) unfractionated suspensions of spleen cells, have the 
capacity for both macrophage and DC differentiation. 
Cytokine-driven propagation and differentiation of high 
numbers of viable DC progenitors from spleen-cell suspen-
sions provides a convenient alternative to traditional labour-
intensive methods of DC enrichment/sorting where low yields/ 
viability and/or contamination can prove problematic. The 
method described also offers opportunities for further 
molecular analyses of the regulation of growth and differentia-
tion of DC lineage cells, and of the mechanism of action of this 
cell lineage in the generation and regulation of adoptive 
immune responses. 
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